The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula wherein is phenyl or a heteroaryl group, selected from pyridinyl, pyrimidinyl, imidazolyl, isoxazolyl or pyrazolyl； is phenyl or pyridinyl, wherein the N atom in the pyridinyl group may be on all free positions； R1 is hydrogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy or halogen； n is 1 or 2； if n is 2, R1 may be the same or not； R2/R2&prime； are independently from each other lower alkyl, or form together with the carbon atom to which they are attached a C3-6-cycloalkyl ring； R3 is lower alkyl, C3-6-cycloalkyl, CH2&mdash；C3-6-cycloalkyl, C3-6-cycloalkyl wherein one ring-carbon atom is replaced by &mdash；O&mdash；, (CH2)3&mdash；O&mdash；C3-6-cycloalkyl, lower alkyl substituted by hydroxy, lower alkyl substituted by halogen, (CH2)3&mdash；S(O)2&mdash；C3-6-cycloalkyl or (CH2)2&mdash；S(O)2-lower alkyl； R4 is hydrogen, halogen or lower alkyl； m is 1 or 2； if m is 2, R4 may be the same or not； as well as with a pharmaceutically acceptable salts thereof, with a racemic mixture, or with its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof.
